Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$27,000.00

The Role of Anti-Leukemia Drug, Homoharringtonine in Skeletal Muscle Hypertrophy

FY 2024-25

Summary
Skeletal muscle undergoes progressive mass and function loss with age, increasing the risk for complications such as weakness and fragility. Currently physical therapy is the main treatment wiht no drugs approved to combat this muscle loss. With this, it is important to investigate drugs that can slow down, prevent or reverse this progressive muscle loss occurring in the elderly as physical therapy may not be suitable for everyone. Homoharringtonine (HHT), an FDA approved anti-leukemia drug was previously shown to increase lean mass in obese aged mice with upregulation of pathways involved in muscle hypertrophy (increase of muscle size) and muscle development seen in HHT treated skeletal muscle. In addition, single nuclei sequencing showed an increase in satellite cell (muscle stem cell) number in HHT treated skeletal muscle. Satellite cells are known to contribute to overall muscle hypertrophy via hyperplasia (increase in cell number) and/or individual muscle fibre hypertrophy. Together, we hypothesize that HHT promotes skeletal muscle hypertrophy through regulation of satellite cell activity. We will determine the effect of HHT on skeletal muscle hypertrophy both In vivo (aged mice) and In vitro (adult muscle cells and muscle precursor cells) as hypertrophic changes can be induced by many factors. Muscle cell size and number will be quantified in addition to the expression of genes related to protein synthesis and degradation. Satellite cell proliferation and differentiation will also be analyzed to understand how HHT effects this population and the involvement of satellite cells in the hypertrophic promoting effect of HHT. This study will benefit the aging population who are at risk of complications from muscle mass and function loss.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
529721
Name
Yew Annie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Role of Anti-Leukemia Drug, Homoharringtonine in Skeletal Muscle Hypertrophy
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aging; Homoharringtonine; Muscle Function Loss; Muscle Mass Loss; Satellite Cells; Skeletal Muscle Hypertrophy; Stem Cells
Abstract
Skeletal muscle undergoes progressive mass and function loss with age, increasing the risk for complications such as weakness and fragility. Currently physical therapy is the main treatment wiht no drugs approved to combat this muscle loss. With this, it is important to investigate drugs that can slow down, prevent or reverse this progressive muscle loss occurring in the elderly as physical therapy may not be suitable for everyone. Homoharringtonine (HHT), an FDA approved anti-leukemia drug was previously shown to increase lean mass in obese aged mice with upregulation of pathways involved in muscle hypertrophy (increase of muscle size) and muscle development seen in HHT treated skeletal muscle. In addition, single nuclei sequencing showed an increase in satellite cell (muscle stem cell) number in HHT treated skeletal muscle. Satellite cells are known to contribute to overall muscle hypertrophy via hyperplasia (increase in cell number) and/or individual muscle fibre hypertrophy. Together, we hypothesize that HHT promotes skeletal muscle hypertrophy through regulation of satellite cell activity. We will determine the effect of HHT on skeletal muscle hypertrophy both In vivo (aged mice) and In vitro (adult muscle cells and muscle precursor cells) as hypertrophic changes can be induced by many factors. Muscle cell size and number will be quantified in addition to the expression of genes related to protein synthesis and degradation. Satellite cell proliferation and differentiation will also be analyzed to understand how HHT effects this population and the involvement of satellite cells in the hypertrophic promoting effect of HHT. This study will benefit the aging population who are at risk of complications from muscle mass and function loss.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yew, Annie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~